Biofrontera Warrants Stock Today
Biofrontera Warrants is selling for under 0.0565 as of the 21st of March 2025; that is 7.38 percent down since the beginning of the trading day. The stock's lowest day price was 0.0565. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Valuation
Check how we calculate scores
Biofrontera Stock Highlights
| President CEO | Hermann Luebbert |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
| Financial Strength | |
Biofrontera Warrants (BFRIW) is traded on NASDAQ Exchange in USA. It is located in 120 Presidential Way, Woburn, MA, United States, 01801 and employs 83 people. Biofrontera Warrants is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry.
Biofrontera Warrants generates negative cash flow from operations
Check Biofrontera Warrants Probability Of Bankruptcy
Biofrontera Warrants Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Biofrontera Warrants market risk premium is the additional return an investor will receive from holding Biofrontera Warrants long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0225 | |||
| Jensen Alpha | 0.0764 | |||
| Total Risk Alpha | 2.25 | |||
| Sortino Ratio | 0.0187 |
Biofrontera Stock Against Markets
Biofrontera Warrants Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biofrontera Warrants stock to make a market-neutral strategy. Peer analysis of Biofrontera Warrants could also be used in its relative valuation, which is a method of valuing Biofrontera Warrants by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Biofrontera Warrants Corporate Management
| Jon MBA | Vice Affairs | Profile | |
| Daniel JD | General Compliance | Profile | |
| Mark Baldyga | Vice Marketing | Profile | |
| Alycia Torres | Vice Administration | Profile | |
| Samantha Widdicombe | Senior Communications | Profile | |
| Eugene III | Chief Officer | Profile |
Additional Tools for Biofrontera Stock Analysis
When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.